Carbapenem resistance in Acinetobacter baumannii: Where is it heading?;Resistenza ai carbapenemi in Acinetobacter baumannii: Where is it heading?

Infezioni in Medicina

Volumn 21, Issue 3, 2013, Pages 211-215

  Deveci, Özcam ^a   Dal, Tuba ^a   Tekin, Recep ^a   Bozkurt, Fatma ^a   Tekin, Alicem ^a   Dayan, Saim ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Acinetobacter baumannii; Antimicrobial susceptibility testing; Carbapenem; Health care associated infections

Indexed keywords

AMIKACIN; CARBAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM COLONY; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD SAMPLING; CASE CONTROL STUDY; DISK DIFFUSION; HEALTHCARE ASSOCIATED INFECTION; HUMAN; NONHUMAN; PROSPECTIVE STUDY; URINALYSIS; URINARY TRACT INFECTION; WOUND INFECTION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CROSS INFECTION; HOSPITALS, UNIVERSITY; HUMANS; IMIPENEM; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; PROGNOSIS; RISK FACTORS; THIENAMYCINS; TURKEY;

EID: 84884175140     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Weber D.J., Baasch R., Rutala W.A. Nosocomial infections in the ICU. The growing importance of antibiotic resistant pathogens. Chest. 115, 34-41, 1999.
2. Çetin E.S., Kaya S., Pakbath Ý., Demirci M. Youn Bakým Ünitelerinde Yatan Hastalardan Ýzole Edilen Mikroorganizmalar ve Antibiyotik Duyarlýlýklarý. Ýnönü. Üniv. Týp Fak. Derg. 14, 69-73, 2007.
3. Paterson D.L. Restrictive antibiotic policies are appropriate in intensive care units. Crit. Care Med. 31, 2528, 2003.
4. Flournoy D.J., Reinert R.L., Bell-Dixon C., Gentry C.A. Increasing antimicrobial resistance in gram-negative bacilli isolated from patients in intensive care units. Am. J. Infect. Control. 28, 244-250, 2000.
5. Mansur A., Kuzucu Ç., Ersoy Y., Yetkin F. Ýnönü Üniversitesi Turgut Özal Týp Merkezinde 2008 Yýlýnda Yatan Hastalardan Ýzole edilen Acinetobacter Su{thorn}larýnýn Antibiotik Duyarlýlýklarý. ANKEM Derg. 23, 177-181, 2009.
6. Maragakis L.L., Perl T.M. Epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis. 46, 1254-1263, 2008.
7. Saltodlu N. Acinetobacter baumannii infeksiyonlarý ve tedavisi. XIII. Türk Klinik Mikrobiyoloji ve Ýnfeksiyon Hastalýklarý Kongresi, Antalya 2007, 204-207. KLÝMÝK Dernei, Ýstanbul.
8. Pachon Ibanez M.E., Jimenez Mejias M.E., Pichardo C., Llanos A.C., Pachon J. Activity of tigecyline (GAR936) against Acinetobacter baumannii strains, including those resistant to imipenem. Antimicrob. Agent Chemother. 48, 4479-4481, 2004.
9. http://health.utah.gov/epi/diseases/legionella/plan/cdcdefsnosocomial%20 infection.pdf
10. Gazi H., Sürücüo{thorn}lu S., Kurutepe S., Ýnmez E., Dinç G., Özbakkalo{thorn}lu B. Youn bakým ünitesinde ve dier ünitelerde yatan hastalardan izole edilen Acinetobacter baumannii su{thorn}larýnda in-vitro antibiyotik direnci. ANKEM Derg. 19, 115-118, 2005.
11. Özer M., Tatman Otkun M., M.mith D., Otkun M. Youn bakým ünitesinde hastane infeksiyonu etkenleri, antibiyotik duyarlýlýklarý ve antibiyotik kullanýmý. Ýnfeksiyon Derg. 20, 165-170, 2006.
12. Bayram A., Balcý Ý. Patterns of antimicrobial resistance in a surgical intensive care unit of a university hospital in Turkey. BMC Infect. Dis. 6, 155, 2006.
13. Appleman M.D., Belzberg H., Citron D.M., et al. In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak. Antimicrob. Agents Chemother. 44, 1035-1040, 2000.
14. Bergogne-Bérézin E., Towner K.J. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 2, 148-165, 196.
15. Arman D. Gram Negatif Bakteri Ýnfeksiyonlarýnda Direnç Sorunu ve Tedavi Önerileri. Hastane enfeksiyonlarý kongre kitabý. 54-57, 2010.
16. Eser Ö.K., Kocagöz S., Ergin A., Altun B., Hasçelik G. Youn Bakým Ünitelerinde Enfeksiyon Etkeni Olan Gram Negatif Basillerin Deerlendirilmesi. Ýnfeksiyon Derg. 19, 75-80, 2005.
17. Çolpan A., Güngör Th., Baykam N., Dokuzouz B. Youn bakým ünitelerinden izole edilen Acinetobacter su{thorn}larýnýn antibiyotik direnç durumlarýnýn ara{thorn}týrýlmasý. Ýnfeksiyon Derg. 16, 55-58, 2002.
18. Ruiz J., Nunez M.L., Perez J., Simarro E., MartinezCampos L., Gomez J. Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period. Eur. J. Clin. Microb. Infect. Dis. 18, 292-295, 1999.
19. Mera R.M., Miller L.A., Amrine-Madsen H., Sahm D.F. Acinetobacter baumannii 2002-2008: increase of carbapenem-associated multiclass resistance in the United States. Microb. Drug Resist. 16, 209-215, 2010.
20. He C., Xie Y., Zhang L., et al. Increasing imipenem resistance and dissemination of the ISAba1-associated blaOXA-23 gene among Acinetobacter baumannii isolates in an intensive care unit. Med. Microbiol. 60, 337-341, 2011.